Which has better valuation and earnings, GNCAQ or CLVR?

Genocea Biosciences has higher earnings, but lower revenue than Clever Leaves. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Genocea Biosciences N/A N/A N/A N/A N/A Clever Leaves $17.42M 0.00 -$17.90M -$12.36 N/A

Is GNCAQ or CLVR more profitable?

Company Net Margins Return on Equity Return on Assets Genocea Biosciences N/A N/A N/A Clever Leaves N/A N/A N/A

Which has preferable earnings & valuation, TRVN or GNCAQ?

Genocea Biosciences has lower revenue, but higher earnings than Trevena. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Trevena $443K 0.02 -$40.29M -$47.04 N/A Genocea Biosciences N/A N/A N/A N/A N/A

Is TRVN or GNCAQ more profitable?

Company Net Margins Return on Equity Return on Assets Trevena N/A N/A -119.55% Genocea Biosciences N/A N/A N/A

Which has stronger earnings & valuation, NAVB or GNCAQ?

Genocea Biosciences has lower revenue, but higher earnings than Navidea Biopharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Navidea Biopharmaceuticals $8.13K 0.00 -$15.18M -$0.21 N/A Genocea Biosciences N/A N/A N/A N/A N/A

Is NAVB or GNCAQ more profitable?

Company Net Margins Return on Equity Return on Assets Navidea Biopharmaceuticals N/A N/A N/A Genocea Biosciences N/A N/A N/A

Which has better earnings and valuation, GNCA or GNCAQ?

Genocea Biosciences has lower revenue, but higher earnings than Genocea Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Genocea Biosciences $1.91M 0.00 -$33.20M -$0.61 N/A Genocea Biosciences N/A N/A N/A N/A N/A

Is GNCA or GNCAQ more profitable?

Genocea Biosciences' return on equity of 0.00% beat Genocea Biosciences' return on equity. Company Net Margins Return on Equity Return on Assets Genocea Biosciences N/A -182.88% -62.76% Genocea Biosciences N/A N/A N/A

Which has preferable valuation and earnings, GNCAQ or PXMD?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Genocea Biosciences N/A N/A N/A N/A N/A PaxMedica N/A N/A -$18.29M -$6.09 N/A

Is GNCAQ or PXMD more profitable?

Genocea Biosciences' return on equity of 0.00% beat PaxMedica's return on equity. Company Net Margins Return on Equity Return on Assets Genocea Biosciences N/A N/A N/A PaxMedica N/A -3,167.89% -560.35%

Genocea Biosciences (GNCAQ) Competitors

Compare

GNCAQ vs. CLVR, TRVN, NAVB, GNCA, and PXMD

Should you buy Genocea Biosciences stock or one of its competitors? MarketBeat compares Genocea Biosciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Genocea Biosciences include Clever Leaves (CLVR), Trevena (TRVN), Navidea Biopharmaceuticals (NAVB), Genocea Biosciences (GNCA), and PaxMedica (PXMD). These companies are all part of the "pharmaceutical products" industry.

How does Genocea Biosciences compare to Clever Leaves?

Genocea Biosciences (NASDAQ:GNCAQ) and Clever Leaves (NASDAQ:CLVR) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, media sentiment, analyst recommendations, risk and institutional ownership.

In the previous week, Genocea Biosciences' average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score.

Company	Overall Sentiment
Genocea Biosciences	Neutral
Clever Leaves	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Genocea Biosciences	N/A	N/A	N/A
Clever Leaves	N/A	N/A	N/A

Genocea Biosciences has higher earnings, but lower revenue than Clever Leaves.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genocea Biosciences	N/A	N/A	N/A	N/A	N/A
Clever Leaves	$17.42M	0.00	-$17.90M	-$12.36	N/A

Genocea Biosciences has a beta of 2.44, indicating that its stock price is 144% more volatile than the broader market. Comparatively, Clever Leaves has a beta of 3816.13, indicating that its stock price is 381,513% more volatile than the broader market.

6.9% of Clever Leaves shares are held by institutional investors. 1.6% of Genocea Biosciences shares are held by insiders. Comparatively, 8.2% of Clever Leaves shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Clever Leaves beats Genocea Biosciences on 4 of the 5 factors compared between the two stocks.

How does Genocea Biosciences compare to Trevena?

Trevena (NASDAQ:TRVN) and Genocea Biosciences (NASDAQ:GNCAQ) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

In the previous week, Trevena's average media sentiment score of 0.00 equaled Genocea Biosciences'average media sentiment score.

Company	Overall Sentiment
Trevena	Neutral
Genocea Biosciences	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Trevena	N/A	N/A	-119.55%
Genocea Biosciences	N/A	N/A	N/A

13.6% of Trevena shares are owned by institutional investors. 2.7% of Trevena shares are owned by company insiders. Comparatively, 1.6% of Genocea Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Genocea Biosciences has lower revenue, but higher earnings than Trevena.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Trevena	$443K	0.02	-$40.29M	-$47.04	N/A
Genocea Biosciences	N/A	N/A	N/A	N/A	N/A

Trevena has a beta of 0.18, meaning that its share price is 82% less volatile than the broader market. Comparatively, Genocea Biosciences has a beta of 2.44, meaning that its share price is 144% more volatile than the broader market.

Summary

Trevena beats Genocea Biosciences on 4 of the 6 factors compared between the two stocks.

How does Genocea Biosciences compare to Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals (NYSE:NAVB) and Genocea Biosciences (NASDAQ:GNCAQ) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

Company	Net Margins	Return on Equity	Return on Assets
Navidea Biopharmaceuticals	N/A	N/A	N/A
Genocea Biosciences	N/A	N/A	N/A

0.0% of Navidea Biopharmaceuticals shares are owned by institutional investors. 43.7% of Navidea Biopharmaceuticals shares are owned by insiders. Comparatively, 1.6% of Genocea Biosciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Genocea Biosciences has lower revenue, but higher earnings than Navidea Biopharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Navidea Biopharmaceuticals	$8.13K	0.00	-$15.18M	-$0.21	N/A
Genocea Biosciences	N/A	N/A	N/A	N/A	N/A

Navidea Biopharmaceuticals has a beta of 1.76, indicating that its share price is 76% more volatile than the broader market. Comparatively, Genocea Biosciences has a beta of 2.44, indicating that its share price is 144% more volatile than the broader market.

In the previous week, Navidea Biopharmaceuticals' average media sentiment score of 0.00 equaled Genocea Biosciences'average media sentiment score.

Company	Overall Sentiment
Navidea Biopharmaceuticals	Neutral
Genocea Biosciences	Neutral

Summary

Navidea Biopharmaceuticals beats Genocea Biosciences on 3 of the 5 factors compared between the two stocks.

How does Genocea Biosciences compare to Genocea Biosciences?

Genocea Biosciences (NASDAQ:GNCA) and Genocea Biosciences (NASDAQ:GNCAQ) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment.

Genocea Biosciences has a beta of 1.61, meaning that its share price is 61% more volatile than the broader market. Comparatively, Genocea Biosciences has a beta of 2.44, meaning that its share price is 144% more volatile than the broader market.

In the previous week, Genocea Biosciences' average media sentiment score of 0.00 equaled Genocea Biosciences'average media sentiment score.

Company	Overall Sentiment
Genocea Biosciences	Neutral
Genocea Biosciences	Neutral

0.6% of Genocea Biosciences shares are owned by institutional investors. 1.6% of Genocea Biosciences shares are owned by company insiders. Comparatively, 1.6% of Genocea Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Genocea Biosciences' return on equity of 0.00% beat Genocea Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genocea Biosciences	N/A	-182.88%	-62.76%
Genocea Biosciences	N/A	N/A	N/A

Genocea Biosciences has lower revenue, but higher earnings than Genocea Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genocea Biosciences	$1.91M	0.00	-$33.20M	-$0.61	N/A
Genocea Biosciences	N/A	N/A	N/A	N/A	N/A

Summary

Genocea Biosciences beats Genocea Biosciences on 4 of the 6 factors compared between the two stocks.

How does Genocea Biosciences compare to PaxMedica?

Genocea Biosciences (NASDAQ:GNCAQ) and PaxMedica (NASDAQ:PXMD) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genocea Biosciences	N/A	N/A	N/A	N/A	N/A
PaxMedica	N/A	N/A	-$18.29M	-$6.09	N/A

In the previous week, Genocea Biosciences' average media sentiment score of 0.00 equaled PaxMedica'saverage media sentiment score.

Company	Overall Sentiment
Genocea Biosciences	Neutral
PaxMedica	Neutral

Genocea Biosciences has a beta of 2.44, indicating that its share price is 144% more volatile than the broader market. Comparatively, PaxMedica has a beta of -0.99, indicating that its share price is 199% less volatile than the broader market.

Genocea Biosciences' return on equity of 0.00% beat PaxMedica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genocea Biosciences	N/A	N/A	N/A
PaxMedica	N/A	-3,167.89%	-560.35%

4.9% of PaxMedica shares are owned by institutional investors. 1.6% of Genocea Biosciences shares are owned by insiders. Comparatively, 1.0% of PaxMedica shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Genocea Biosciences beats PaxMedica on 4 of the 6 factors compared between the two stocks.

Get Genocea Biosciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GNCAQ vs. The Competition

Export

Metric	Genocea Biosciences	Biological Products Industry	Medical Sector	NASDAQ Exchange
Market Cap	$5K	$357.18M	$6.87B	$12.26B
Dividend Yield	N/A	N/A	2.67%	9.79%
P/E Ratio	0.00	N/A	27.14	23.64
Price / Sales	N/A	228.84	517.06	88.99
Price / Cash	N/A	22.44	50.54	59.64
Price / Book	N/A	4.88	10.28	6.07
Net Income	N/A	-$141.03M	$3.60B	$331.99M

Genocea Biosciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GNCAQ Genocea Biosciences	N/A	N/A	N/A	N/A	$5K	N/A	N/A	70	High Trading Volume
CLVR Clever Leaves	N/A	$0.01 flat	N/A	+3,250.0%	$18K	$17.42M	N/A	560
TRVN Trevena	N/A	$0.01 flat	N/A	-98.8%	$11K	$443K	N/A	40	Gap Up
NAVB Navidea Biopharmaceuticals	N/A	N/A	N/A	N/A	$10K	$8.13K	N/A	10
GNCA Genocea Biosciences	N/A	N/A	N/A	N/A	$6K	$1.91M	N/A	70

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GNCAQ) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Genocea Biosciences (GNCAQ) Competitors

GNCAQ vs. CLVR, TRVN, NAVB, GNCA, and PXMD

How does Genocea Biosciences compare to Clever Leaves?

Summary

How does Genocea Biosciences compare to Trevena?

Summary

How does Genocea Biosciences compare to Navidea Biopharmaceuticals?

Summary

How does Genocea Biosciences compare to Genocea Biosciences?

Summary

How does Genocea Biosciences compare to PaxMedica?

Summary

Media Sentiment Over Time

GNCAQ vs. The Competition

Genocea Biosciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Genocea Biosciences (GNCAQ) Competitors

GNCAQ vs. CLVR, TRVN, NAVB, GNCA, and PXMD

How does Genocea Biosciences compare to Clever Leaves?

Does the media favor GNCAQ or CLVR?

Is GNCAQ or CLVR more profitable?

Which has better valuation and earnings, GNCAQ or CLVR?

Which has more volatility and risk, GNCAQ or CLVR?

Do institutionals & insiders have more ownership in GNCAQ or CLVR?

Summary

How does Genocea Biosciences compare to Trevena?

Does the media prefer TRVN or GNCAQ?

Is TRVN or GNCAQ more profitable?

Do institutionals & insiders have more ownership in TRVN or GNCAQ?

Which has preferable earnings & valuation, TRVN or GNCAQ?

Which has more risk & volatility, TRVN or GNCAQ?

Summary

How does Genocea Biosciences compare to Navidea Biopharmaceuticals?

Is NAVB or GNCAQ more profitable?

Do institutionals and insiders hold more shares of NAVB or GNCAQ?

Which has stronger earnings & valuation, NAVB or GNCAQ?

Which has more risk and volatility, NAVB or GNCAQ?

Does the media prefer NAVB or GNCAQ?

Summary

How does Genocea Biosciences compare to Genocea Biosciences?

Which has more volatility and risk, GNCA or GNCAQ?

Does the media refer more to GNCA or GNCAQ?

Do insiders and institutionals hold more shares of GNCA or GNCAQ?

Is GNCA or GNCAQ more profitable?

Which has better earnings and valuation, GNCA or GNCAQ?

Summary

How does Genocea Biosciences compare to PaxMedica?

Which has preferable valuation and earnings, GNCAQ or PXMD?

Does the media prefer GNCAQ or PXMD?

Which has more risk & volatility, GNCAQ or PXMD?

Is GNCAQ or PXMD more profitable?

Do insiders and institutionals have more ownership in GNCAQ or PXMD?

Summary

Media Sentiment Over Time

GNCAQ vs. The Competition

Genocea Biosciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools